BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

684 related articles for article (PubMed ID: 19205571)

  • 1. Seroprevalence of Toxoplasma gondii infection in Kwal, a rural distriction of Plateau-Nigeria.
    Uneke CJ; Duhlinska DD; Ngwu BA; Njoku MO
    Afr J Med Med Sci; 2007 Jun; 36(2):109-13. PubMed ID: 19205571
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Seroprevalence of acquired toxoplasmosis in HIV-infected and apparently healthy individuals in Jos, Nigeria.
    Uneke CJ; Duhlinska DD; Njoku MO; Ngwu BA
    Parassitologia; 2005 Jun; 47(2):233-6. PubMed ID: 16252478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Seroepidemiological study of toxoplasmosis in different sections of population of Union Territory of Chandigarh.
    Mohan B; Dubey ML; Malla N; Kumar R
    J Commun Dis; 2002 Mar; 34(1):15-22. PubMed ID: 12718337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Seroprevalence of Toxoplasma gondii antibodies amongst pregnant women at the Lagos State University Teaching Hospital, Nigeria.
    Akinbami AA; Adewunmi AA; Rabiu KA; Wright KO; Dosunmu AO; Dada MO; Adeyemo TA
    Niger Postgrad Med J; 2010 Jun; 17(2):164-7. PubMed ID: 20539334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Seroprevalence of Toxoplasma antibodies among individuals tested at hospitals and private laboratories in Beirut.
    Bouhamdan SF; Bitar LK; Saghir HJ; Bayan A; Araj GF
    J Med Liban; 2010; 58(1):8-11. PubMed ID: 20358853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Seroprevalence and associated risk factors of toxoplasmosis in pregnant women in Hebron district, Palestine.
    Nijem KI; Al-Amleh S
    East Mediterr Health J; 2009; 15(5):1278-84. PubMed ID: 20214142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Seroprevalence of specific total immunoglobulin (Ig), IgG and IgM antibodies to Toxoplasma gondii in blood donors from Loei Province, Northeast Thailand.
    Pinlaor S; Ieamviteevanich K; Pinlaor P; Maleewong W; Pipitgool V
    Southeast Asian J Trop Med Public Health; 2000 Mar; 31(1):123-7. PubMed ID: 11023078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High prevalence of antibody to Toxoplasma gondii among humans in Surabaya, Indonesia.
    Konishi ; Houki Y; Harano K; Mibawani RS; Marsudi D; Alibasah S; Dachlan YP
    Jpn J Infect Dis; 2000 Dec; 53(6):238-41. PubMed ID: 11227021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Seroepidemiology of Toxoplasma gondii infection in pregnant women in rural Durango, Mexico.
    Alvarado-Esquivel C; Torres-Castorena A; Liesenfeld O; García-López CR; Estrada-Martínez S; Sifuentes-Alvarez A; Marsal-Hernández JF; Esquivel-Cruz R; Sandoval-Herrera F; Castañeda JA; Dubey JP
    J Parasitol; 2009 Apr; 95(2):271-4. PubMed ID: 18922040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The status of infection with Toxoplasma gondii in the Swiss population: contribution of a seroepidemiologic study from the Zurich canton].
    Jacquier P; Nadal D; Zuber P; Eckert J
    Schweiz Med Wochenschr Suppl; 1995; 65():23S-28S. PubMed ID: 7716450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-Toxoplasma gondii antibodies in hemodialysis patients receiving long-term hemodialysis therapy in Turkey.
    Ocak S; Duran N; Eskiocak AF; Aytac H
    Saudi Med J; 2005 Sep; 26(9):1378-82. PubMed ID: 16155651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Toxoplasma gondii infection in Amerindians of Venezuelan Amazon].
    de la Rosa M; Bolívar J; Pérez HA
    Medicina (B Aires); 1999; 59(6):759-62. PubMed ID: 10752222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Occurrence of Toxoplasma gondii antibodies in the population of Split-Dalmatia County].
    Tonkić M; Punda-Polić V; Sardelić S; Capkun V
    Lijec Vjesn; 2002; 124(1-2):19-22. PubMed ID: 12038093
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Seroepidemiology of Toxoplasma gondii infection in human adults from three rural communities in Durango State, Mexico.
    Alvarado-Esquivel C; Cruz-Magallanes HM; Esquivel-Cruz R; Estrada-Martínez S; Rivas-González M; Liesenfeld O; Martínez-García SA; Ramírez E; Torres-Castorena A; Castañeda A; Dubey JP
    J Parasitol; 2008 Aug; 94(4):811-6. PubMed ID: 18576838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Seroepidemiology of infection with Toxoplasma gondii in waste pickers and waste workers in Durango, Mexico.
    Alvarado-Esquivel C; Liesenfeld O; Márquez-Conde JA; Cisneros-Camacho A; Estrada-Martínez S; Martínez-García SA; González-Herrera A; García-Corral N
    Zoonoses Public Health; 2008 Aug; 55(6):306-12. PubMed ID: 18489540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Seroprevalence of infection with Toxoplasma gondii in indigenous Brazilian populations.
    Sobral CA; Amendoeira MR; Teva A; Patel BN; Klein CH
    Am J Trop Med Hyg; 2005 Jan; 72(1):37-41. PubMed ID: 15728865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toxoplasma gondii infection and schizophrenia: a case control study in a low Toxoplasma seroprevalence Mexican population.
    Alvarado-Esquivel C; Urbina-Álvarez JD; Estrada-Martínez S; Torres-Castorena A; Molotla-de-León G; Liesenfeld O; Dubey JP
    Parasitol Int; 2011 Jun; 60(2):151-5. PubMed ID: 21292026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Seroprevalence of cytomegalovirus and Toxoplasma gondii in healthy subjects under 30 years old in Santiago, Chile].
    Abarca K; Vial PA; Zamorano J; Paris C; Ferrés M; Villarroel L; Ferreccio C
    Rev Med Chil; 1997 May; 125(5):531-8. PubMed ID: 9497573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Seroprevalence of Toxoplasma gondii in northern Greece during the last 20 years.
    Diza E; Frantzidou F; Souliou E; Arvanitidou M; Gioula G; Antoniadis A
    Clin Microbiol Infect; 2005 Sep; 11(9):719-23. PubMed ID: 16104986
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Seroprevalence of human toxoplasmosis.
    Gutiérrez J; Roldán C; Maroto MC
    Microbios; 1996; 85(343):73-5. PubMed ID: 8643032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.